120 related articles for article (PubMed ID: 12458837)
1. From taxol to Taxol: the changing identities and ownership of an anti-cancer drug.
Walsh V; Goodman J
Med Anthropol; 2002; 21(3-4):307-36. PubMed ID: 12458837
[TBL] [Abstract][Full Text] [Related]
2. New treatment for ovarian cancer poses ecology dilemma.
Crumbie A
Nurs Times; 1994 Jun 15-21; 90(24):34-5. PubMed ID: 7913219
[TBL] [Abstract][Full Text] [Related]
3. Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug taxol.
Walsh V; Goodman J
Soc Sci Med; 1999 Nov; 49(9):1215-25. PubMed ID: 10501642
[TBL] [Abstract][Full Text] [Related]
4. Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
Wall ME; Wani MC
Cancer Res; 1995 Feb; 55(4):753-60. PubMed ID: 7850785
[TBL] [Abstract][Full Text] [Related]
5. Nutrition and food commodities in the 20th century.
Martini SA; Phillips M
J Agric Food Chem; 2009 Sep; 57(18):8130-5. PubMed ID: 19719130
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. The early regulation of figs in the United States.
Young JH
Technology; 1999; 6():229-34. PubMed ID: 11623766
[TBL] [Abstract][Full Text] [Related]
8. Sure cure: public policy on drug efficacy before 1962.
Swann JP
Publ Am Inst Hist Pharm; 1997; 16():223-61. PubMed ID: 11619897
[No Abstract] [Full Text] [Related]
9. Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
Adams JD; Flora KP; Goldspiel BR; Wilson JW; Arbuck SG; Finley R
J Natl Cancer Inst Monogr; 1993; (15):141-7. PubMed ID: 7912520
[TBL] [Abstract][Full Text] [Related]
10. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
11. Taxol and related compounds in Korean native yews (Taxus cuspidata).
Choi MS; Kwak SS; Liu JR; Park YG; Lee MK; An NH
Planta Med; 1995 Jun; 61(3):264-6. PubMed ID: 7617770
[TBL] [Abstract][Full Text] [Related]
12. [Taxol--a new cytostatic drug for therapy of ovarian and breast cancer].
Meden H; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):187-93. PubMed ID: 7912212
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence: the regulatory career of a pharmaceutical concept.
Carpenter D; Tobbell DA
Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
[TBL] [Abstract][Full Text] [Related]
14. The evolution of national nutrition policy.
Kessler DA
Annu Rev Nutr; 1995; 15():xiii-xxvi. PubMed ID: 8527212
[TBL] [Abstract][Full Text] [Related]
15. Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.
Segreti AC; Leung HM; Koch GG; Davis RL; Mohberg NR; Peace KE
J Biopharm Stat; 2001 Nov; 11(4):347-72. PubMed ID: 12018784
[TBL] [Abstract][Full Text] [Related]
16. Drug development history, "overview," and what are GCPs?
Heilman RD
Qual Assur; 1995 Mar; 4(1):75-9. PubMed ID: 8520867
[TBL] [Abstract][Full Text] [Related]
17. FDA advisors recommend approval of taxol for node-positive breast cancer.
Oncologist; 1999; 4(5):430-1. PubMed ID: 10551561
[No Abstract] [Full Text] [Related]
18. Taxol: a new and effective anti-cancer drug.
Slichenmyer WJ; Von Hoff DD
Anticancer Drugs; 1991 Dec; 2(6):519-30. PubMed ID: 1687206
[TBL] [Abstract][Full Text] [Related]
19. Rewiring cellular metabolism for heterologous biosynthesis of Taxol.
Nazhand A; Durazzo A; Lucarini M; Mobilia MA; Omri B; Santini A
Nat Prod Res; 2020 Jan; 34(1):110-121. PubMed ID: 31298589
[TBL] [Abstract][Full Text] [Related]
20. Taxol: initial Israeli experience with a novel anticancer agent.
Sulkes A; Beller U; Peretz T; Shacter J; Hornreich G; McDaniel C; Winograd B
Isr J Med Sci; 1994 Jan; 30(1):70-8. PubMed ID: 7908013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
